Uma Prabhakar

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

Uma Prabhakar, Hiroshi Maeda, Eva M. Sevick‐Muraca et al. · Cancer Research · 2013 · 1.5K citations

Pharmacy, Oncology, Pharmaceutics +17

Comparative analysis of lymphocyte activation marker expression and cytokine secretion profile in stimulated human peripheral blood mononuclear cell cultures: an in vitro model to monitor cellular immune function

Manjula Reddy, Edward Eirikis, Cuc Davis et al. · Journal of Immunological Methods · 2004 · 295 citations

Life Sciences, Cell Biology, Immunology +16

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

Sylvie Négrier, Nicholas D. James, Ivo Kocák et al. · British Journal of Cancer · 2010 · 188 citations · Full text

Medicine, Immunology, Oncology +17

Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP™ assay

Uma Prabhakar, Edward Eirikis, Hugh M. Davis · Journal of Immunological Methods · 2002 · 184 citations

Life Sciences, Immunology, Clinical Biochemistry +11

A clinical study assessing the tolerability and biological effects of infliximab, a TNF-α inhibitor, in patients with advanced cancer

Ewan Brown, Kellie A. Charles, Susan Hoare et al. · Annals of Oncology · 2008 · 182 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13